After donating $176 million in proceeds from his original stock options in 2023, Stéphane Bancel is taking a different path ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

Moderna, Inc. has rallied ~23%, but rated a Sell due to deteriorating fundamentals. Learn more about MRNA stock here.

The latest trading day saw Moderna (MRNA) settling at $32.29, representing a -7.48% change from its previous close.

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced it would ...

Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.8% in the afternoon session after the stock's positive momentum continued as the Coalition for Epidemic Preparedness Innovations (CEPI) ...

Get the live share price of Moderna Inc (MRNA), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the afternoon session after the broader ...

Top large-cap gainers for Dec. 15–19 were led by Rivian, Moderna, and BioMarin, rising on product/software updates, vaccine ...

What To Know: A memo obtained by NBC News said Prasad told FDA staff that an internal review found at least 10 child deaths "after and because of receiving" the Covid vaccine, citing reports in the ...

Nvidia (NVDA) shares recently found strong buying support at below $175. That led to an uptrend, followed by a 3.01% lift for ...